Spironolactone And Hydrochlorothiazide Tablet
Product Images NDC 48433-090

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone And Hydrochlorothiazide (NDC 48433-090). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Safecor Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spironolactone Structural Formula (Image 01)

FDA Label Image

Hydrochlorothiazide Structural Formula (Image 02)

Hydrochlorothiazide Structural Formula (Image 02)
This is not-available as it contains mostly symbols and not readable characters.*
FDA Label Image

Unit Carton (Image 03)

Unit Carton (Image 03)
This text appears to be a description of a child-resistant heat seal container suitable for institutional use. It emphasizes the features of child-resistant packaging, including a secure closure to prevent access by children. The container also includes a window for viewing the contents and expiration date. The product is distributed by Safecor Health LLC in Rockford, Illinois, USA. Additionally, contact information for Safecor Health Company is provided as 1-800-447-1006 and SafecorHealth.com.*
FDA Label Image

Spironolactone And Hydrochlorothiazide 25 mg/25 mg Tablets, Usp Unit Carton Label (Image 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.